Primary focal segmental glomerulosclerosis in Egyptian children: a 10-year single-centre experience

Pediatr Nephrol. 2010 Jul;25(7):1369-73. doi: 10.1007/s00467-010-1448-7. Epub 2010 Mar 2.

Abstract

Primary focal segmental glomerulosclerosis (FSGS) in children accounts for 7-20% of all cases of idiopathic nephrotic syndrome (NS). To evaluate the clinical course of children with primary FSGS, the records of 72 patients with biopsy-proven FSGS admitted between 1995 and 2008 were retrospectively analysed. Forty-eight patients were male (66.7%). The mean age at presentation was 76.5 +/- 54 (range 12-192) months. The mean duration of follow-up was 76.3 +/- 42 (range 9-156) months. Seventeen patients (23.6%) presented with gross haematuria at initial presentation, 15 (20.8%) presented with hypertension and 10 patients (14%) presented with chronic renal insufficiency (CRI). The initial response to oral prednisolone was steroid resistance in 63 patients (87.5%) and steroid dependence in 4 patients (5%), while 5 patients (6.9%) were biopsied from the start because of atypical presentation. According to pathological classification, there were the tip variant (2%), collapsing variant (6%), perihilar variant (7%) and NOS (not otherwise specified; 85%). At the last clinical visit, 12 patients (16.7%) were in complete remission and 11 (15.3%) had progressed to CRI. Renal survival rates at 5 and 10 years were 93% and 68%, respectively. In conclusion, in this study we had a low percentage of FSGS, and fewer patients presenting with gross haematuria and hypertension compared with previous reports. In addition, the short-term overall renal survival seems to be better in our cohort.

MeSH terms

  • Adolescent
  • Biopsy
  • Child
  • Child, Preschool
  • Cohort Studies
  • Comorbidity
  • Cyclosporine / therapeutic use
  • Drug Therapy, Combination
  • Egypt / epidemiology
  • Female
  • Glomerulosclerosis, Focal Segmental / drug therapy
  • Glomerulosclerosis, Focal Segmental / epidemiology*
  • Glomerulosclerosis, Focal Segmental / pathology
  • Hematuria / drug therapy
  • Hematuria / epidemiology*
  • Hematuria / etiology
  • Humans
  • Hypertension / epidemiology*
  • Hypertension / etiology
  • Hypertension / pathology
  • Infant
  • Kidney Failure, Chronic / epidemiology*
  • Kidney Failure, Chronic / pathology
  • Male
  • Methylprednisolone / therapeutic use
  • Renal Insufficiency, Chronic / drug therapy
  • Renal Insufficiency, Chronic / epidemiology*
  • Renal Insufficiency, Chronic / pathology
  • Retrospective Studies

Substances

  • Cyclosporine
  • Methylprednisolone